# HCN2

## Overview
The HCN2 gene encodes the hyperpolarization-activated cyclic nucleotide-gated potassium and sodium channel 2, a transmembrane protein that is part of the HCN channel family. These channels are integral to the generation of pacemaker currents in cardiac and neuronal tissues, playing a pivotal role in regulating heart rate and neuronal excitability. The HCN2 protein is characterized by six transmembrane domains and a cyclic nucleotide-binding domain (CNBD), which modulates its activity through the binding of cyclic adenosine monophosphate (cAMP). This modulation is crucial for the channel's function in both cardiac and nervous systems, where it influences processes such as heart rhythm and synaptic transmission. Mutations in the HCN2 gene have been linked to various neurological disorders, including epilepsy and neuropathic pain, underscoring its clinical significance (WahlSchott2008HCN; Emery2012HCN2; Vaccari1999The).

## Structure
The HCN2 protein is a member of the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel family, characterized by its structure comprising six transmembrane domains (S1-S6) and a pore region between S5 and S6 (WahlSchott2008HCN; Vaccari1999The). The S4 segment functions as a voltage sensor, containing positively charged residues that respond to changes in membrane potential (WahlSchott2008HCN; Baruscotti2010HCNrelated). The C-terminal region of HCN2 includes a cyclic nucleotide-binding domain (CNBD), which is crucial for the modulation of channel activity by cyclic adenosine monophosphate (cAMP) (WahlSchott2008HCN; Baruscotti2010HCNrelated).

The CNBD is composed of approximately 120 amino acids and features a conserved fold with an A-helix, an eight-stranded antiparallel β-roll, a short B-helix, and a long C-helix (WahlSchott2008HCN). The HCN2 protein forms tetrameric structures, which are typical of pore-loop channels, allowing for the conduction of Na+ and K+ ions (WahlSchott2008HCN; Baruscotti2010HCNrelated). The binding of cAMP to the CNBD induces a conformational change that facilitates channel opening, highlighting the dynamic nature of its tertiary structure (WahlSchott2008HCN). Common post-translational modifications, such as phosphorylation, can influence the activity of HCN2 channels, although specific modifications are not detailed in the provided context.

## Function
The HCN2 gene encodes a protein that forms part of the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel family, which plays a crucial role in generating pacemaker currents in cardiac sinoatrial node myocytes and central neurons. These channels are characterized by six transmembrane domains and a cyclic nucleotide-binding domain (CNBD) that modulates channel activity through the binding of cyclic AMP (cAMP) (WahlSchott2008HCN; Vaccari1999The).

HCN2 channels are involved in regulating the heart's pacemaker activity by contributing to the ionic currents that control heart rate. They exhibit mixed Na+ and K+ permeability and are activated upon hyperpolarization, with their activity modulated by cAMP, which shifts the voltage-dependence of activation to more positive voltages, resulting in larger currents (WahlSchott2008HCN; Moroni2000Kinetic).

In the nervous system, HCN2 channels help set and stabilize the resting membrane potential in neurons, influencing synaptic transmission and dendritic integration. They are involved in processes like long-term potentiation and working memory by modulating synaptic input efficiency and network activity (WahlSchott2008HCN). The channels are widely distributed in the brain, with significant expression in the thalamus and brainstem nuclei (WahlSchott2008HCN).

## Clinical Significance
Mutations in the HCN2 gene are associated with various neurological conditions, particularly epilepsy and neuropathic pain. Pathogenic variants in HCN2 have been linked to a range of epileptic syndromes, including absence seizures, febrile seizures, generalized epilepsy, and genetic epilepsy with febrile seizures plus (GEFS+) (Kessi2022The). Specific mutations such as p.S632W and delPPP (p.719-721) are associated with febrile seizures and generalized epilepsy, often exhibiting gain-of-function effects that lead to increased neuronal excitability (Dibbens2010Augmented; Kessi2022The). The E515K mutation, a loss-of-function variant, is linked to idiopathic generalized epilepsy and results in increased neuronal excitability due to a significant negative shift in the activation curve of the channels (DiFrancesco2011Recessive).

HCN2 is also implicated in pain modulation. Alterations in HCN2 expression are associated with neuropathic pain conditions, such as diabetic neuropathy and chemotherapy-induced neuropathic pain. HCN2 channels contribute to the initiation of neuronal excitability following nerve injury, and their pharmacological inhibition has been suggested as a potential treatment for neuropathic pain (Emery2012HCN2). These findings highlight the clinical significance of HCN2 in both epilepsy and pain disorders.

## Interactions
HCN2 interacts with several proteins that modulate its function and expression. One significant interaction is with the protein TRIP8b, which binds to HCN2 at two distinct sites. This interaction affects channel trafficking and inhibits cAMP-dependent potentiation. TRIP8b reduces the effects of cAMP on the voltage-dependence and rate of activation of HCN2, as well as the cAMP-dependent increase in maximal current amplitude. TRIP8b preferentially binds to the cAMP-free CNBD, stabilizing the cAMP-unbound state and affecting the channel's response to cAMP (Santoro2004Regulation; Peters2022Regulation).

HCN2 also interacts with KCNE2, a regulatory β-subunit that increases the current densities of HCN2 and affects its activation kinetics. KCNE2 increases the membrane protein levels of HCN2 and modulates its single channel properties, such as increasing single channel amplitudes and conductance (Brandt2009Effects).

Additionally, HCN2 co-distributes with SAP97 in the sinoatrial node, suggesting a role in organizing HCN channels within specific domains. This interaction is dependent on the PDZ compatible binding motif at the C-terminus of HCN2 (Peters2009In).


## References


[1. (Dibbens2010Augmented) Leanne M. Dibbens, Christopher A. Reid, Bree Hodgson, Evan A. Thomas, Alison M. Phillips, Elena Gazina, Brett A. Cromer, Alison L. Clarke, Tallie Z. Baram, Ingrid E. Scheffer, Samuel F. Berkovic, and Steven Petrou. Augmented currents of an hcn2 variant in patients with febrile seizure syndromes. Annals of Neurology, 67(4):542–546, April 2010. URL: http://dx.doi.org/10.1002/ana.21909, doi:10.1002/ana.21909. This article has 91 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.21909)

[2. (Baruscotti2010HCNrelated) Mirko Baruscotti, Georgia Bottelli, Raffaella Milanesi, Jacopo C. DiFrancesco, and Dario DiFrancesco. Hcn-related channelopathies. Pflügers Archiv - European Journal of Physiology, 460(2):405–415, March 2010. URL: http://dx.doi.org/10.1007/s00424-010-0810-8, doi:10.1007/s00424-010-0810-8. This article has 72 citations.](https://doi.org/10.1007/s00424-010-0810-8)

[3. (Peters2022Regulation) Colin H. Peters, Rohit K. Singh, John R. Bankston, and Catherine Proenza. Regulation of hcn channels by protein interactions. Frontiers in Physiology, June 2022. URL: http://dx.doi.org/10.3389/fphys.2022.928507, doi:10.3389/fphys.2022.928507. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2022.928507)

[4. (Vaccari1999The) T. Vaccari, A. Moroni, M. Rocchi, L. Gorza, M.E. Bianchi, M. Beltrame, and D. DiFrancesco. The human gene coding for hcn2, a pacemaker channel of the heart. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1446(3):419–425, September 1999. URL: http://dx.doi.org/10.1016/s0167-4781(99)00092-5, doi:10.1016/s0167-4781(99)00092-5. This article has 57 citations.](https://doi.org/10.1016/s0167-4781(99)00092-5)

[5. (Santoro2004Regulation) Bina Santoro, Brian J. Wainger, and Steven A. Siegelbaum. Regulation of hcn channel surface expression by a novel c-terminal protein-protein interaction. The Journal of Neuroscience, 24(47):10750–10762, November 2004. URL: http://dx.doi.org/10.1523/JNEUROSCI.3300-04.2004, doi:10.1523/jneurosci.3300-04.2004. This article has 264 citations.](https://doi.org/10.1523/JNEUROSCI.3300-04.2004)

[6. (Kessi2022The) Miriam Kessi, Jing Peng, Haolin Duan, Hailan He, Baiyu Chen, Juan Xiong, Ying Wang, Lifen Yang, Guoli Wang, Karlmax Kiprotich, Olumuyiwa A. Bamgbade, Fang He, and Fei Yin. The contribution of hcn channelopathies in different epileptic syndromes, mechanisms, modulators, and potential treatment targets: a systematic review. Frontiers in Molecular Neuroscience, May 2022. URL: http://dx.doi.org/10.3389/fnmol.2022.807202, doi:10.3389/fnmol.2022.807202. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2022.807202)

[7. (DiFrancesco2011Recessive) Jacopo C. DiFrancesco, Andrea Barbuti, Raffaella Milanesi, Stefania Coco, Annalisa Bucchi, Georgia Bottelli, Carlo Ferrarese, Silvana Franceschetti, Benedetta Terragni, Mirko Baruscotti, and Dario DiFrancesco. Recessive loss-of-function mutation in the pacemaker hcn2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy. The Journal of Neuroscience, 31(48):17327–17337, November 2011. URL: http://dx.doi.org/10.1523/JNEUROSCI.3727-11.2011, doi:10.1523/jneurosci.3727-11.2011. This article has 119 citations.](https://doi.org/10.1523/JNEUROSCI.3727-11.2011)

[8. (Peters2009In) Christian J. Peters, Sarah S. Chow, Damiano Angoli, Hamed Nazzari, Francisco S. Cayabyab, Ala Morshedian, and Eric A. Accili. In situ co-distribution and functional interactions of sap97 with sinoatrial isoforms of hcn channels. Journal of Molecular and Cellular Cardiology, 46(5):636–643, May 2009. URL: http://dx.doi.org/10.1016/j.yjmcc.2009.01.010, doi:10.1016/j.yjmcc.2009.01.010. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.yjmcc.2009.01.010)

[9. (WahlSchott2008HCN) C. Wahl-Schott and M. Biel. Hcn channels: structure, cellular regulation and physiological function. Cellular and Molecular Life Sciences, 66(3):470–494, October 2008. URL: http://dx.doi.org/10.1007/s00018-008-8525-0, doi:10.1007/s00018-008-8525-0. This article has 324 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-008-8525-0)

[10. (Emery2012HCN2) Edward C. Emery, Gareth T. Young, and Peter A. McNaughton. Hcn2 ion channels: an emerging role as the pacemakers of pain. Trends in Pharmacological Sciences, 33(8):456–463, August 2012. URL: http://dx.doi.org/10.1016/j.tips.2012.04.004, doi:10.1016/j.tips.2012.04.004. This article has 96 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.tips.2012.04.004)

[11. (Moroni2000Kinetic) Anna Moroni, Andrea Barbuti, Claudia Altomare, Carlo Viscomi, Julie Morgan, Mirko Baruscotti, and Dario DiFrancesco. Kinetic and ionic properties of the human hcn2 pacemaker channel. Pflügers Archiv, 439(5):618–626, March 2000. URL: http://dx.doi.org/10.1007/s004249900225, doi:10.1007/s004249900225. This article has 30 citations.](https://doi.org/10.1007/s004249900225)

[12. (Brandt2009Effects) Mathias C. Brandt, Jeannette Endres-Becker, Naufal Zagidullin, Lukas J. Motloch, Fikret Er, Dennis Rottlaender, Guido Michels, Stefan Herzig, and Uta C. Hoppe. Effects of kcne2 on hcn isoforms: distinct modulation of membrane expression and single channel properties. American Journal of Physiology-Heart and Circulatory Physiology, 297(1):H355–H363, July 2009. URL: http://dx.doi.org/10.1152/ajpheart.00154.2009, doi:10.1152/ajpheart.00154.2009. This article has 27 citations.](https://doi.org/10.1152/ajpheart.00154.2009)